You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
During the first year of the TRIDENT-2 study, 74,000 women opted for NIPT, which was switched from in-house-developed platforms to Illumina's VeriSeq in May of this year.
The thousands of differentially acetylated peaks were enriched in regions harboring genes with disease-related pathology.
In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.
Researchers documented genetic associations, trait heritability, and more with data from GWAS on 778 binary or non-binary traits in UK Biobank participants.
With CE-IVD marking, the melt curve analysis-based screening assay is available for sale in the EU and other areas that recognize the designation.
In the Finnish GeneRisk study, patients at high risk for heart disease were especially motivated to take action if their polygenic risk score was high.
Last week, GenomeWeb's readers were most interested in Illumina's selection of five new startups for the eighth funding cycle of its accelerator program.
OncoDNA anticipates a strong increase in the use of OncoDNA profiling products in Europe with the partnerships with Gammaray and AMS.
A brief recap of Genetics/Genomics news the week of Oct 19, 2018: Bruker, OneOme, Barclays, Congenica, BC Platforms, Medicover, DNAnexus, and Myriad Genetics
In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.
The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.
Researchers have sequenced the genome of "the Methuselah of freshwater fish."
The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.
In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.